FCGR3A and tuberculosis: We could observe that low responder TB patients (LR-TB) presented higher percentages of circulating CD14++CD16+ and CD14+CD16++ monocytes and M-MDSC as compared to high responder patients (HR-TB) and healthy donors (HD).